RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 84 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q4 2014. The put-call ratio across all filers is 2.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,229,000 | +67.2% | 136,963 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $735,000 | +31.5% | 136,963 | +12.8% | 0.00% | 0.0% |
| Q1 2016 | $559,000 | -11.4% | 121,418 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $631,000 | -11.0% | 121,418 | +3.6% | 0.00% | 0.0% |
| Q3 2015 | $709,000 | -90.4% | 117,244 | -74.9% | 0.00% | -92.9% |
| Q2 2015 | $7,386,000 | +641.6% | 467,744 | +410.7% | 0.01% | +600.0% |
| Q1 2015 | $996,000 | +8.5% | 91,583 | +5.0% | 0.00% | 0.0% |
| Q4 2014 | $918,000 | +9.7% | 87,257 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $837,000 | -17.0% | 87,257 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,008,000 | +16.4% | 87,257 | +0.7% | 0.00% | 0.0% |
| Q1 2014 | $866,000 | -20.3% | 86,616 | +3.8% | 0.00% | 0.0% |
| Q4 2013 | $1,086,000 | -4.1% | 83,406 | +10.1% | 0.00% | -33.3% |
| Q3 2013 | $1,132,000 | +64.8% | 75,766 | +3.2% | 0.00% | +50.0% |
| Q2 2013 | $687,000 | – | 73,437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|